Xilis is a startup based in the United States, most recent round Series B, 3 tracked investors.
Based in the United States, Xilis is a startup founded in 2015. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Xilis develops a patient-derived microtumor platform to predict drug response and guide personalized cancer treatment in oncology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.